Cargando…
Validation of the Japanese version of the Body Image Scale for bladder cancer patients
The Body Image Scale (BIS) is a 10-item tool that measures the body images of cancer patients. This study aims to validate the Japanese version of the BIS for bladder cancer patients. A multicenter cross-sectional survey was used to identify the participants, which included Japanese bladder cancer p...
Autores principales: | Sato, Miho, Osawa, Takahiro, Abe, Takashige, Honda, Michitaka, Higuchi, Madoka, Yamada, Shuhei, Furumido, Jun, Kikuchi, Hiroshi, Matsumoto, Ryuji, Sato, Yasuyuki, Sasaki, Yoshihiro, Harabayashi, Toru, Maruyama, Satoru, Takada, Norikata, Minami, Keita, Tanaka, Hiroshi, Morita, Ken, Kashiwagi, Akira, Murai, Sachiyo, Ito, Yoichi M., Ogasawara, Katsuhiko, Shinohara, Nobuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747706/ https://www.ncbi.nlm.nih.gov/pubmed/36513724 http://dx.doi.org/10.1038/s41598-022-25669-2 |
Ejemplares similares
-
Health-related quality of life in Japanese patients with bladder cancer measured by a newly developed Japanese version of the Bladder Cancer Index
por: Osawa, Takahiro, et al.
Publicado: (2020) -
Comparative study of lymph node dissection, and oncological outcomes of laparoscopic and open radical nephroureterectomy for patients with urothelial carcinoma of the upper urinary tract undergoing regional lymph node dissection
por: Abe, Takashige, et al.
Publicado: (2018) -
Perioperative morbidity and mortality of octogenarians treated by radical cystectomy—a multi-institutional retrospective study in Japan
por: Abe, Takashige, et al.
Publicado: (2017) -
Outcome and prognostic factors in metastatic urothelial carcinoma patients receiving second-line chemotherapy: an analysis of real-world clinical practice data in Japan
por: Matsumoto, Ryuji, et al.
Publicado: (2018) -
Outcomes of bacillus Calmette–Guérin therapy without a maintenance schedule for high‐risk non‐muscle‐invasive bladder cancer in the second transurethral resection era
por: Kikuchi, Hiroshi, et al.
Publicado: (2021)